<h4>Background/objectives</h4>Vaccines targeting melanoma antigens can elicit CD8<sup>+</sup> T cell responses, but a growing body of work suggests CD4<sup>+</sup> T cells also play a role in tumor control. This evidence concerns the gene CD8A and melanoma.